Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Scheriproct Suppositories

{email} Notify me of changes to this product

emc account functionality

Sign in or register for an emc account to use this functionality and much more:

  • Get the latest updates to your inbox

    Receive email notifications when chosen products are updated

  • Stay up to date with document change history

    Get full access to document change history

  • Similar product search

    Use active ingredient, company or ATC code

  • Save your regular searches

    Simple access to search enquiries every time you need them

  • Favourite products you use most often

    Helps you find products you use regularly as fast as possible

About Medicine
Product Information – Scheriproct Suppositories change of ownership

Please note that following a Change of Ownership, Karo Pharma are now Marketing Authorisation Holder for Scheriproct Suppositories.

For a period of time you may still receive packs of Scheriproct Suppositories in LEO Laboratories Limited packaging, displaying a LEO Laboratories Limited Marketing Authorisation number.

Please contact Karo Pharma for any queries related to this product.

Email: [email protected]
Tel: 0-808-189-4327

Karo Pharma AB
Company image
Address
Klara Norra Kyrkogata 33, Stockholm, Sweden
Telephone
+44 (0) 8000461977
Medical Information Direct Line
+44 (0) 8000461977
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 8000461977
Stock Availability
[email protected]